Cargando…

Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]

Detalles Bibliográficos
Autores principales: Bu, Wenhuan, Wang, Zilin, Meng, Lin, Li, Xing, Liu, Xinchen, Chen, Yumeng, Xin, Ying, Li, Baoquan, Sun, Hongchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535437/
https://www.ncbi.nlm.nih.gov/pubmed/31191022
http://dx.doi.org/10.2147/CMAR.S214609
_version_ 1783421572146528256
author Bu, Wenhuan
Wang, Zilin
Meng, Lin
Li, Xing
Liu, Xinchen
Chen, Yumeng
Xin, Ying
Li, Baoquan
Sun, Hongchen
author_facet Bu, Wenhuan
Wang, Zilin
Meng, Lin
Li, Xing
Liu, Xinchen
Chen, Yumeng
Xin, Ying
Li, Baoquan
Sun, Hongchen
author_sort Bu, Wenhuan
collection PubMed
description
format Online
Article
Text
id pubmed-6535437
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65354372019-06-12 Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum] Bu, Wenhuan Wang, Zilin Meng, Lin Li, Xing Liu, Xinchen Chen, Yumeng Xin, Ying Li, Baoquan Sun, Hongchen Cancer Manag Res Corrigendum Dove 2019-05-22 /pmc/articles/PMC6535437/ /pubmed/31191022 http://dx.doi.org/10.2147/CMAR.S214609 Text en © 2019 Bu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Corrigendum
Bu, Wenhuan
Wang, Zilin
Meng, Lin
Li, Xing
Liu, Xinchen
Chen, Yumeng
Xin, Ying
Li, Baoquan
Sun, Hongchen
Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
title Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
title_full Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
title_fullStr Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
title_full_unstemmed Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
title_short Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
title_sort disulfiram inhibits epithelial–mesenchymal transition through tgfβ–erk–snail pathway independently of smad4 to decrease oral squamous cell carcinoma metastasis [corrigendum]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535437/
https://www.ncbi.nlm.nih.gov/pubmed/31191022
http://dx.doi.org/10.2147/CMAR.S214609
work_keys_str_mv AT buwenhuan disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT wangzilin disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT menglin disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT lixing disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT liuxinchen disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT chenyumeng disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT xinying disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT libaoquan disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum
AT sunhongchen disulfiraminhibitsepithelialmesenchymaltransitionthroughtgfberksnailpathwayindependentlyofsmad4todecreaseoralsquamouscellcarcinomametastasiscorrigendum